Ubiquitination in signaling to and activation of IKK

Research output: Contribution to journalArticle

221 Citations (Scopus)

Abstract

A role for polyubiquitination in the activation of inhibitor of NF-κB (IκB) kinase (IKK) through a proteasome-independent mechanism was first reported in 1996, but the physiological significance of this finding was not clear until 2000 when TRAF6 was found to be a ubiquitin E3 ligase that catalyzes lysine-63 (K63) polyubiquitination. Since then, several proteins known to regulate IKK have been linked to the ubiquitin pathway. These include the deubiquitination enzymes CYLD and A20 that inhibit IKK, and the ubiquitin binding proteins NEMO and TAB2 which are the regulatory subunits of IKK and TAK1 kinase complexes, respectively. Now accumulating evidence strongly supports a central role of K63 polyubiquitination in IKK activation by multiple immune and inflammatory pathways. Interestingly, recent research suggests that some alternative ubiquitin chains such as linear or K11 ubiquitin chains may also play a role in certain pathways such as the TNF pathway. Here I present a historical narrative of the discovery of the role of ubiquitin in IKK activation, review recent advances in understanding the role and mechanism of ubiquitin-mediated IKK activation, and raise some questions to be resolved in future research.

Original languageEnglish (US)
Pages (from-to)95-106
Number of pages12
JournalImmunological Reviews
Volume246
Issue number1
DOIs
StatePublished - Mar 2012

Fingerprint

Ubiquitination
Ubiquitin
Phosphotransferases
TNF Receptor-Associated Factor 6
Ubiquitin-Protein Ligases
Proteasome Endopeptidase Complex
Lysine
Carrier Proteins
Enzymes
Research
Proteins

Keywords

  • IKK
  • MAVS
  • NF-κB
  • RIG-I
  • TAK1
  • Ubiquitin

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Ubiquitination in signaling to and activation of IKK. / Chen, Zhijian J.

In: Immunological Reviews, Vol. 246, No. 1, 03.2012, p. 95-106.

Research output: Contribution to journalArticle

@article{da7879efd0114482a6a148291b09bbd1,
title = "Ubiquitination in signaling to and activation of IKK",
abstract = "A role for polyubiquitination in the activation of inhibitor of NF-κB (IκB) kinase (IKK) through a proteasome-independent mechanism was first reported in 1996, but the physiological significance of this finding was not clear until 2000 when TRAF6 was found to be a ubiquitin E3 ligase that catalyzes lysine-63 (K63) polyubiquitination. Since then, several proteins known to regulate IKK have been linked to the ubiquitin pathway. These include the deubiquitination enzymes CYLD and A20 that inhibit IKK, and the ubiquitin binding proteins NEMO and TAB2 which are the regulatory subunits of IKK and TAK1 kinase complexes, respectively. Now accumulating evidence strongly supports a central role of K63 polyubiquitination in IKK activation by multiple immune and inflammatory pathways. Interestingly, recent research suggests that some alternative ubiquitin chains such as linear or K11 ubiquitin chains may also play a role in certain pathways such as the TNF pathway. Here I present a historical narrative of the discovery of the role of ubiquitin in IKK activation, review recent advances in understanding the role and mechanism of ubiquitin-mediated IKK activation, and raise some questions to be resolved in future research.",
keywords = "IKK, MAVS, NF-κB, RIG-I, TAK1, Ubiquitin",
author = "Chen, {Zhijian J.}",
year = "2012",
month = "3",
doi = "10.1111/j.1600-065X.2012.01108.x",
language = "English (US)",
volume = "246",
pages = "95--106",
journal = "Immunological Reviews",
issn = "0105-2896",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Ubiquitination in signaling to and activation of IKK

AU - Chen, Zhijian J.

PY - 2012/3

Y1 - 2012/3

N2 - A role for polyubiquitination in the activation of inhibitor of NF-κB (IκB) kinase (IKK) through a proteasome-independent mechanism was first reported in 1996, but the physiological significance of this finding was not clear until 2000 when TRAF6 was found to be a ubiquitin E3 ligase that catalyzes lysine-63 (K63) polyubiquitination. Since then, several proteins known to regulate IKK have been linked to the ubiquitin pathway. These include the deubiquitination enzymes CYLD and A20 that inhibit IKK, and the ubiquitin binding proteins NEMO and TAB2 which are the regulatory subunits of IKK and TAK1 kinase complexes, respectively. Now accumulating evidence strongly supports a central role of K63 polyubiquitination in IKK activation by multiple immune and inflammatory pathways. Interestingly, recent research suggests that some alternative ubiquitin chains such as linear or K11 ubiquitin chains may also play a role in certain pathways such as the TNF pathway. Here I present a historical narrative of the discovery of the role of ubiquitin in IKK activation, review recent advances in understanding the role and mechanism of ubiquitin-mediated IKK activation, and raise some questions to be resolved in future research.

AB - A role for polyubiquitination in the activation of inhibitor of NF-κB (IκB) kinase (IKK) through a proteasome-independent mechanism was first reported in 1996, but the physiological significance of this finding was not clear until 2000 when TRAF6 was found to be a ubiquitin E3 ligase that catalyzes lysine-63 (K63) polyubiquitination. Since then, several proteins known to regulate IKK have been linked to the ubiquitin pathway. These include the deubiquitination enzymes CYLD and A20 that inhibit IKK, and the ubiquitin binding proteins NEMO and TAB2 which are the regulatory subunits of IKK and TAK1 kinase complexes, respectively. Now accumulating evidence strongly supports a central role of K63 polyubiquitination in IKK activation by multiple immune and inflammatory pathways. Interestingly, recent research suggests that some alternative ubiquitin chains such as linear or K11 ubiquitin chains may also play a role in certain pathways such as the TNF pathway. Here I present a historical narrative of the discovery of the role of ubiquitin in IKK activation, review recent advances in understanding the role and mechanism of ubiquitin-mediated IKK activation, and raise some questions to be resolved in future research.

KW - IKK

KW - MAVS

KW - NF-κB

KW - RIG-I

KW - TAK1

KW - Ubiquitin

UR - http://www.scopus.com/inward/record.url?scp=84863338304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863338304&partnerID=8YFLogxK

U2 - 10.1111/j.1600-065X.2012.01108.x

DO - 10.1111/j.1600-065X.2012.01108.x

M3 - Article

C2 - 22435549

AN - SCOPUS:84863338304

VL - 246

SP - 95

EP - 106

JO - Immunological Reviews

JF - Immunological Reviews

SN - 0105-2896

IS - 1

ER -